Overview
Panagiotis Petrou practices in Nicosia, Cyprus. Mr. Petrou is rated as an Experienced expert by MediFind in the treatment of 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency. His top areas of expertise are 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, Renal Cell Carcinoma (RCC), End-Stage Renal Disease (ESRD), Pompe Disease, and Transcatheter Aortic Valve Replacement (TAVR).
His clinical research consists of co-authoring 46 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency
- Breast CancerMr. Petrou isExperienced. Learn about Breast Cancer.
- End-Stage Renal Disease (ESRD)Mr. Petrou isExperienced. Learn about End-Stage Renal Disease (ESRD).
- Gaucher DiseaseMr. Petrou isExperienced. Learn about Gaucher Disease.
- Pompe DiseaseMr. Petrou isExperienced. Learn about Pompe Disease.
- Renal Cell Carcinoma (RCC)Mr. Petrou isExperienced. Learn about Renal Cell Carcinoma (RCC).